A Phase I Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed and/or Refractory Multiple Myeloma
This study is currently recruiting participants.
Verified August 2013 by Emory University
Multiple Myeloma Research Consortium
Onyx Therapeutics, Inc.
Information provided by (Responsible Party):
Jonathan Kaufman, Emory University
First received: March 7, 2012
Last updated: August 14, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||January 2015|
|Estimated Primary Completion Date:||January 2014 (Final data collection date for primary outcome measure)|